US HB2889 | 2017-2018 | 115th Congress
Status
Sponsorship: Slight Partisan Bill (Democrat 3-1)
Status: Introduced on June 13 2017 - 25% progression, died in committee
Action: 2017-06-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 13 2017 - 25% progression, died in committee
Action: 2017-06-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Closing Loopholes for Orphan Drugs Act This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
Title
Closing Loopholes for Orphan Drugs Act
Sponsors
| Sen. Peter Welch [D-VT] | Rep. Gregg Harper [R-MS] | Rep. Collin Peterson [D-MN] | Rep. Peter Visclosky [D-IN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2017-06-16 | House | Referred to the Subcommittee on Health. |
| 2017-06-13 | House | Referred to the House Committee on Energy and Commerce. |
| 2017-06-13 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/house-bill/2889/all-info |
| Text | https://www.congress.gov/115/bills/hr2889/BILLS-115hr2889ih.pdf |
